Skip to content

Author

Yanmei Chen

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.

The historical milestones in ERK1/2 research are outlined, from their discovery and structural characterization to their identification as oncogenic drivers and therapeutic targets, and the potential of ERK1/2-targeted therapies in precision oncology is highlighted.

Zhi-Qi Peng, Yuqi Fu, Yanmei Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.